| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 07/25/2006 | CA2072785C Pharmacologically active hydrazine derivatives and processes for the preparation thereof |
| 07/20/2006 | WO2006076561A1 Process for preparing amorphous valsartan |
| 07/20/2006 | US20060160856 Diarylurea derivatives and their use as chloride channel blockers |
| 07/20/2006 | US20060160808 New carboxylic acid derivatives, their preparation and their use |
| 07/20/2006 | CA2592307A1 Process for preparing amorphous valsartan |
| 07/19/2006 | CN1805942A Diphenylurea derivatives and their use as chloride channel blockers |
| 07/18/2006 | US7078423 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/18/2006 | US7078013 Pretargeting methods and compounds |
| 07/18/2006 | CA2190727C Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging |
| 07/13/2006 | WO2006074244A2 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 07/13/2006 | US20060154989 For use as contrast media; x-ray diagnosis and magnetic resonance imaging |
| 07/13/2006 | CA2594098A1 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 07/12/2006 | EP1679310A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 07/12/2006 | EP1678162A1 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
| 07/12/2006 | EP1622882B1 A METHOD OF PREPARATION OF N -(1-OXOPENTYL)- N-¬¬ 2-(1TETRAZOL-5-y1) ¬1,1 -BIPHENYL|-4-y1 METHYL| -L-VALINE (VALSARTAN) |
| 07/12/2006 | EP1303499B1 Tetrazole derivatives |
| 07/12/2006 | CN1802159A 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 07/12/2006 | CN1800184A Synthesis of temozolomide and analogs |
| 07/12/2006 | CN1263733C Substituted phenyl derivatives, their preparation and use |
| 07/11/2006 | US7074814 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antiarthritic agents ; psoriasis |
| 07/11/2006 | US7074786 Histogranin-like peptides, processes for their preparation and uses thereof |
| 07/11/2006 | CA2215233C Terminal carboxy or tetrazole groups containing dialkyl ethers |
| 07/06/2006 | WO2005041867A8 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3’(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrozol-3-one choline |
| 07/06/2006 | US20060149079 Process for preparing valsartan |
| 07/04/2006 | US7071358 Lipid diseases; metabolism diosrders; antiproliferative agents |
| 07/04/2006 | US7071231 Especially Type II diabetes; stimulating the kinase activity of the insulin receptor; activating the insulin receptor |
| 07/04/2006 | US7071214 Compounds and compositions for delivering active agents |
| 07/04/2006 | US7071191 Non-imidazole aryloxypiperidines |
| 07/04/2006 | CA2332066C Tetrazole compounds as thyroid receptor ligands |
| 07/04/2006 | CA2250840C Antivirally active heterocyclic azahexane derivatives |
| 06/29/2006 | WO2006067216A2 Intermediate compounds for the preparation of an angiotensin ii receptor and process for the preparation of valsartan |
| 06/29/2006 | WO2006067139A1 Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists |
| 06/29/2006 | WO2006035157A3 Substituted n-(benzyl)phenylacetamide derivative compounds, preparation method thereof and uses of same as ppar ligands in the treatment of lipid and/or glucidic disorders |
| 06/29/2006 | WO2005118715A3 Gas generant and synthesis |
| 06/29/2006 | CA2588028A1 Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists |
| 06/28/2006 | EP1673342A2 Amides that inhibit vanilloid receprot subtype 1 (vr1) receptor |
| 06/28/2006 | EP1673075A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 06/28/2006 | CN1793129A Tech. for synthetic (4-chlorobutyl) 1-cyclohexyl-1,2,3,4-tetrazole |
| 06/28/2006 | CN1261417C Method for producing sulf-5 position substituted tetrazole |
| 06/28/2006 | CN1261416C Perfuoroalkylamide, prodn. and use in diagnostics thereof |
| 06/27/2006 | US7067546 high yield, industrial scale crystallization of 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (Candesartan) from solution or suspension with an aprotic polar solvent, between zero and 30 degrees Celsius |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067506 Compounds useful for inhibiting Chk1 |
| 06/27/2006 | CA2238633C Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
| 06/22/2006 | WO2006064179A1 Process and intermediate compounds useful in the preparation of statins |
| 06/22/2006 | US20060135785 Alpha-phenyl acetanilide derivatives having an acat inhibiting activity and the therapeutic application thereof |
| 06/22/2006 | US20060135773 Trisubstituted nitrogen modulators of tyrosine phosphatases |
| 06/22/2006 | US20060135572 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis |
| 06/22/2006 | US20060135519 5-aryltetrazole compounds and compositions thereof |
| 06/21/2006 | EP1671945A1 Process for production of 1-aryl-5-(trifluoromethyl)-1h- tetrazoles |
| 06/21/2006 | EP1670772A1 Derivatives of 1,3-diones having a herbicidal activity |
| 06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
| 06/20/2006 | US7064117 Anti-cancer 2,3-dihydro-1H-pyrrolo[3,2-f]quinoline complexes of cobalt and chromium |
| 06/20/2006 | US7063928 An apparatus having an organophotoreceptor in the form of a flexible belt threaded around support rollers and having a charge transfer compound comprising a fluorenone hydrazone including other functional groups and phenyl and heteraryl rings;used with liquid toner; durability |
| 06/20/2006 | CA2121523C Sulfonamide derivatives |
| 06/15/2006 | WO2006062093A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | WO2006061706A1 Tetrazolyl-methylene amino acid derivatives |
| 06/15/2006 | US20060128680 porosity; nanostructure |
| 06/15/2006 | US20060128674 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 06/15/2006 | CA2589718A1 Tetrazolyl-methylene amino acid derivatives |
| 06/15/2006 | CA2588633A1 Novel anthranilic acid derivative or salt thereof |
| 06/14/2006 | CN1788004A Polymorphis of valsartan |
| 06/14/2006 | CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 06/14/2006 | CN1259318C Tetrazoyl oxime derivative and agrochemical containing the same as active ingredient |
| 06/13/2006 | US7060818 Synthesis of macrocyclic tetraamido compounds and new metal insertion process |
| 06/13/2006 | US7060718 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular |
| 06/08/2006 | WO2006058701A1 A process for the synthesis of valsartan |
| 06/08/2006 | US20060122242 2-Aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 06/08/2006 | US20060122239 Lipid diseases; metabolism diosrders; antiproliferative agents |
| 06/08/2006 | US20060122231 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity |
| 06/08/2006 | US20060120965 Trimeric, macrocyclically substituted aminoisophthalic acid-halo-benzene derivatives |
| 06/08/2006 | CA2586334A1 Compounds for the treatment of cns and amyloid associated diseases |
| 06/07/2006 | EP1666471A1 Process for producing 2' -(1h-tetrazol-5-yl)-biphenyl-4-carbaldehyde |
| 06/07/2006 | EP1663979A1 Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists |
| 06/07/2006 | EP1663953A1 Inhibitors of histone deacetylase |
| 06/07/2006 | EP1663232A1 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 06/07/2006 | EP1663204A2 C-kit modulators and methods of use |
| 06/07/2006 | EP1663105A2 Cycloalkyl heterocycles for treating hepatitis c virus |
| 06/07/2006 | CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 06/07/2006 | CN1258527C Method for preparing aryl alkyl hydrogen peroxide |
| 06/01/2006 | WO2006057870A1 Potentiators of glutamate receptors |
| 06/01/2006 | WO2006057869A1 Potentiators of glutamate receptors |
| 06/01/2006 | WO2006057860A1 Potentiators of glutamate receptors |
| 06/01/2006 | WO2006056854A1 Dibenzyl amine compounds and derivatives |
| 06/01/2006 | US20060116377 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 06/01/2006 | CA2590349A1 Potentiators of glutamate receptors |
| 06/01/2006 | CA2589322A1 Dibenzyl amine compounds and derivatives |
| 06/01/2006 | CA2588881A1 Potentiators of glutamate receptors |
| 05/31/2006 | EP1661891A1 A process for the synthesis of valsartan |
| 05/31/2006 | EP1660480A1 A process for the preparation of cilostazol and of the intermediates thereof |
| 05/31/2006 | EP1660463A1 A process for the preparation of phenyltetrazole derivatives |
| 05/31/2006 | EP1660137A2 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors |
| 05/31/2006 | EP1659863A2 Pesticidally active phenol derivatives |
| 05/31/2006 | EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/30/2006 | US7053110 Dietetics; osteoporosis; muscular disorders |
| 05/26/2006 | WO2006055187A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 05/26/2006 | CA2585172A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 05/24/2006 | EP1658281A2 A method of removing the triphenylmethane protecting group |
| 05/24/2006 | EP1658264A2 Methods and compositions for treating amyloid-related diseases |